Business Relations Table - o4.fyi ()

Anmelden Gast|Guest
Beispiel: brt.php?search=wide&s=wide&p=adjective&o=wideness

Domain-Statistiken für "hyperiondefi.com"

39
Business Relations
40
Eindeutige Domains
20
Gefundene Einträge
BR-Relations: 39
From Domain Role To Domain Path Aktionen
/p/the-first-nasdaq-listed-hype-treasury-company
/
/profiles/hyunsu-jung
/news-events/press-releases/detail/265/eyenovia-initiates-phase-iii-microstat-program-for-pharmacologic-mydriasis-enrolls-first-patient-in-mist-1-study
/news-events/press-releases/detail/220/eyenovia-to-present-clinical-study-updates-at-the-american-academy-of-optometry-annual-meeting
/news-events/press-releases/detail/220/eyenovia-to-present-clinical-study-updates-at-the-american-academy-of-optometry-annual-meeting
/news-events/press-releases/detail/220/eyenovia-to-present-clinical-study-updates-at-the-american-academy-of-optometry-annual-meeting
/news-events/press-releases/detail/215/eyenovia-announces-first-patients-enrolled-in-phase-3-study-of-microline-for-presbyopia
/news-events/press-releases/detail/212/eyenovia-to-present-at-the-ophthalmology-innovation-summit-ois-presbyopia-innovation-showcase
/news-events/press-releases/detail/212/eyenovia-to-present-at-the-ophthalmology-innovation-summit-ois-presbyopia-innovation-showcase
/news-events/press-releases/detail/208/eyenovia-announces-publication-of-mist-pivotal-studies-demonstrating-the-efficacy-and-safety-of-its-map-fixed-combination-tropicamide-phenylephrine-product-for-mydriasis
/news-events/press-releases/detail/208/eyenovia-announces-publication-of-mist-pivotal-studies-demonstrating-the-efficacy-and-safety-of-its-map-fixed-combination-tropicamide-phenylephrine-product-for-mydriasis
/news-events/press-releases/detail/208/eyenovia-announces-publication-of-mist-pivotal-studies-demonstrating-the-efficacy-and-safety-of-its-map-fixed-combination-tropicamide-phenylephrine-product-for-mydriasis
/news-events/press-releases/detail/206/eyenovia-and-eversana-announce-partnership-to-support-the-potential-launch-and-commercialization-of-mydcombi-for-mydriasis
/news-events/press-releases/detail/198/eyenovia-to-participate-in-two-upcoming-investor-conferences
/news-events/press-releases/detail/197/eyenovia-to-participate-in-a-presbyopia-panel-discussion-at-eyecelerator-2021
/news-events/press-releases/detail/197/eyenovia-to-participate-in-a-presbyopia-panel-discussion-at-eyecelerator-2021
/news-events/press-releases/detail/197/eyenovia-to-participate-in-a-presbyopia-panel-discussion-at-eyecelerator-2021
/news-events/press-releases/detail/197/eyenovia-to-participate-in-a-presbyopia-panel-discussion-at-eyecelerator-2021
/news-events/press-releases/detail/166/eyenovia-to-present-at-the-american-academy-of-optometrys-annual-meeting